(Q36925696)

17 August 2017

1 reference

title

Breast cancer vaccines: promise for the future or pipe dream? (English)

1 reference

17 August 2017

3

S Eva Singletary

1 reference

17 August 2017

author name string

Elizabeth A Mittendorf

series ordinal

1

1 reference

17 August 2017

George E Peoples

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

110

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1677-1686

1 reference

Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

No significant association of Epstein-Barr virus infection with invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Mechanisms of tumor evasion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Vaccine strategies to treat lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Vaccination for leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Carcinoembryonic antigen as a target for cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Response of established human breast tumors to vaccination with mammaglobin-A cDNA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Cell-surface antigens expressed on L-cells transfected with whole DNA from non-expressing and expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

T cell homeostatic proliferation elicits effective antitumor autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Prophylactic human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

SOME POSSIBLE EFFECTS OF NURSING ON THE MAMMARY GLAND TUMOR INCIDENCE IN MICE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Mammary Tumor Viruses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Cancer vaccines: between the idea and the reality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22978

7 January 2021

Identifiers

DOI

10.1002/CNCR.22978

1 reference

17 August 2017

1 reference